Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Chief Financial Officer | December 14, 2009 | December 16, 2009 |
| L3HARRIS TECHNOLOGIES, INC. /DE/HRS · Entity 610 | Director | October 01, 2016 | October 04, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date December 14, 2009 · Filed December 16, 2009
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 207,179.3773 |
Ending reported balance
After 2009-12-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2009-12-14 · Exercise / conversion · Acquired 80,000 · Balance 287,179.3773 Row 2 · 2009-12-14 · Sale · Disposed 80,000 · Balance 207,179.3773 F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $32.30 and $32.45 per share. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $19.28 · Expires 2010-01-03 | Direct | 0 |
Reported balance
After 2009-12-14 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2009-12-14 · Exercise / conversion · Disposed 80,000 · Balance 0 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $30.26 · Expires 2011-03-07 | Direct | 100,000 |
Reported balance
Holding disclosure · report date 2009-12-14 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 100,000 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $17.67 · Expires 2011-01-08 | Direct | 100,000 |
Reported balance
Holding disclosure · report date 2009-12-14 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 100,000 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $12.56 · Expires 2013-01-09 | Direct | 160,000 |
Reported balance
Holding disclosure · report date 2009-12-14 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 160,000 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $22.45 · Expires 2012-01-05 | Direct | 100,000 |
Reported balance
Holding disclosure · report date 2009-12-14 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 100,000 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $30.04 · Expires 2013-04-03 | Direct | 138,309 |
Reported balance
Holding disclosure · report date 2009-12-14 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 138,309 F6: Option becomes exercisable in three equal annual installments, commencing 4/3/2007. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $34.42 · Expires 2014-04-02 | Direct | 136,089 |
Reported balance
Holding disclosure · report date 2009-12-14 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 136,089 F7: Option becomes exercisable in three equal annual installments, commencing 4/2/2008. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $41.17 · Expires 2015-04-01 | Direct | 172,973 |
Reported balance
Holding disclosure · report date 2009-12-14 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 172,973 F8: Option becomes exercisable in three equal annual installments, commencing 4/1/2009. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $28.10 · Expires 2016-04-01 | Direct | 192,709 |
Reported balance
Holding disclosure · report date 2009-12-14 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 192,709 F9: Option becomes exercisable in three equal annual installments, commencing 4/1/2010. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust As Beneficiary | 23,934.4149 |
Reported balance
Holding disclosure · report date 2009-12-14 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 23,934.4149 |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 77,477 |
Reported balance
Holding disclosure · report date 2009-12-14 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 77,477 |
| ESOP Common StockSEC Table I · non-derivative | Indirectby ESOP | 1,720.8481 |
Reported balance
Holding disclosure · report date 2009-12-14 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 1,720.8481 |
| Stock UnitSEC Table I · non-derivative | Direct | 120,769.1132 |
Reported balance
Holding disclosure · report date 2009-12-14 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 120,769.1132 |
| Phantom Stock CreditsSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 | Direct | 15,049 |
Reported balance
Holding disclosure · report date 2009-12-14 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 15,049 F3: Each share credit is equivalent to one share; 1-for-1 conversion. F4: Reflects 2001, 2002 and 2003 year end company match share credits of 846, 29 and 808, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. F5: Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $32.30 and $32.45 per share.
F3: Each share credit is equivalent to one share; 1-for-1 conversion.
F4: Reflects 2001, 2002 and 2003 year end company match share credits of 846, 29 and 808, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F5: Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F6: Option becomes exercisable in three equal annual installments, commencing 4/3/2007.
F7: Option becomes exercisable in three equal annual installments, commencing 4/2/2008.
F8: Option becomes exercisable in three equal annual installments, commencing 4/1/2009.
F9: Option becomes exercisable in three equal annual installments, commencing 4/1/2010.
L3HARRIS TECHNOLOGIES, INC. /DE/
Report date October 01, 2016 · Filed October 04, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 72,871.04 |
Reported balance
After 2016-10-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2016-10-01 · Grant · Acquired 368.41 · Balance 72,871.04 F1: Each phantom stock unit is the economic equivalent of one share of the Issuer's common stock. F2: The phantom stock units were awarded on October 1, 2016 pursuant to an automatic quarterly grant under the Harris Corporation 2005 Directors' Deferred Compensation Plan. The phantom stock units are to be settled in cash upon the reporting person's retirement or other events. The reporting person may also transfer the phantom stock units into alternative investment accounts in certain other instances if applicable ownership guidelines are satisfied. F3: The aggregate of 72,871.04 phantom stock units includes: (a) 1,315.84 phantom stock units acquired through dividend reinvestment in the Harris Corporation Directors' Deferred Compensation Plans ("Plans") from 3/8/16 through 9/7/16 and (b) a reduction of a .20 phantom stock unit due to rounding of previous reports by the Plans' record keeper. |
Filing footnotes · ownership attribution and instrument terms
F1: Each phantom stock unit is the economic equivalent of one share of the Issuer's common stock.
F2: The phantom stock units were awarded on October 1, 2016 pursuant to an automatic quarterly grant under the Harris Corporation 2005 Directors' Deferred Compensation Plan. The phantom stock units are to be settled in cash upon the reporting person's retirement or other events. The reporting person may also transfer the phantom stock units into alternative investment accounts in certain other instances if applicable ownership guidelines are satisfied.
F3: The aggregate of 72,871.04 phantom stock units includes: (a) 1,315.84 phantom stock units acquired through dividend reinvestment in the Harris Corporation Directors' Deferred Compensation Plans ("Plans") from 3/8/16 through 9/7/16 and (b) a reduction of a .20 phantom stock unit due to rounding of previous reports by the Plans' record keeper.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
DOLLAR GENERAL CORP
Report date May 30, 2018 · Filed May 31, 2018
Section 16 reporting ended · disclosed 2018-05-31. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,342 |
Reported balance
After 2018-05-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-05-30 · Disposition to issuer · Disposed 1.8539 · Balance 15,342 F1: Represents the cashout of fractional shares resulting from the accelerated vesting of certain restricted stock units and the payment of certain deferred shares upon retirement from the Dollar General Corporation Board of Directors. F2: Includes 78.0768 additional restricted stock units, which were acquired through exempt transactions as a result of dividend equivalent rights on July 25, 2017, October 24, 2017, January 23, 2018, and April 24, 2018, representing the right to receive shares of common stock upon vesting and/or payment. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the cashout of fractional shares resulting from the accelerated vesting of certain restricted stock units and the payment of certain deferred shares upon retirement from the Dollar General Corporation Board of Directors.
F2: Includes 78.0768 additional restricted stock units, which were acquired through exempt transactions as a result of dividend equivalent rights on July 25, 2017, October 24, 2017, January 23, 2018, and April 24, 2018, representing the right to receive shares of common stock upon vesting and/or payment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2018 Filed May 31, 2018 23:20 UTC | DOLLAR GENERAL CORP DG · Entity 2133 | Disposition to issuerCommon Stock | 1.8539 | $96.52 | $178.94 |
DisclosureSEC source: 0000029534-18-000041 · edgar.xml · nonDerivative · entry 1 RICKARD DAVID B · CIK 0001194414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,342 F1 · shares: Represents the cashout of fractional shares resulting from the accelerated vesting of certain restricted stock units and the payment of certain deferred shares upon retirement from the Dollar General Corporation Board of Directors. F2 · balance_after: Includes 78.0768 additional restricted stock units, which were acquired through exempt transactions as a result of dividend equivalent rights on July 25, 2017, October 24, 2017, January 23, 2018, and April 24, 2018, representing the right to receive shares of common stock upon vesting and/or payment. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 13:02 UTC | DOLLAR GENERAL CORP DG · Entity 2133 | GrantCommon Stock | 1,895 | $0.00 | $0.00 |
DisclosureSEC source: 0000029534-17-000047 · edgar.xml · nonDerivative · entry 1 RICKARD DAVID B · CIK 0001194414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,265.7771 F1 · shares: Restricted stock units representing the right to receive shares of common stock upon vesting. The restricted stock units vest on May 31, 2018, subject to certain forfeiture and accelerated vesting provisions. Read SEC document |
| May 25, 2017 Filed May 26, 2017 18:25 UTC | DOLLAR GENERAL CORP DG · Entity 2133 | Disposition to issuerCommon Stock | 0.3666 | $72.47 | $26.57 |
DisclosureSEC source: 0000029534-17-000036 · edgar.xml · nonDerivative · entry 1 RICKARD DAVID B · CIK 0001194414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,370.7771 F1 · shares: Represents the cashout of a fractional share resulting from the vesting of certain restricted stock units. F2 · balance_after: Includes 80.0699 additional restricted stock units, which were acquired through exempt transactions as a result of dividend equivalent rights on June 29, 2016, September 28, 2016, January 4, 2017 and April 25, 2017, representing the right to receive shares of common stock upon vesting. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 18:42 UTC | L3HARRIS TECHNOLOGIES, INC. /DE/ HRS · Entity 610 | GrantPhantom Stock Units · Derivative | 368.41 | $91.61 | $33,750.04 |
DisclosureSEC source: 0001209191-16-144024 · doc4.xml · derivative · entry 1 RICKARD DAVID B · CIK 0001194414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,871.04 Underlying: Common Stock, Par Value $1.00 · 368.41 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: The phantom stock units were awarded on October 1, 2016 pursuant to an automatic quarterly grant under the Harris Corporation 2005 Directors' Deferred Compensation Plan. The phantom stock units are to be settled in cash upon the reporting person's retirement or other events. The reporting person may also transfer the phantom stock units into alternative investment accounts in certain other instances if applicable ownership guidelines are satisfied. F2 · derivative.expiration_date: The phantom stock units were awarded on October 1, 2016 pursuant to an automatic quarterly grant under the Harris Corporation 2005 Directors' Deferred Compensation Plan. The phantom stock units are to be settled in cash upon the reporting person's retirement or other events. The reporting person may also transfer the phantom stock units into alternative investment accounts in certain other instances if applicable ownership guidelines are satisfied. F3 · balance_after: The aggregate of 72,871.04 phantom stock units includes: (a) 1,315.84 phantom stock units acquired through dividend reinvestment in the Harris Corporation Directors' Deferred Compensation Plans ("Plans") from 3/8/16 through 9/7/16 and (b) a reduction of a .20 phantom stock unit due to rounding of previous reports by the Plans' record keeper. Read SEC document |
| December 14, 2009 Filed Dec 16, 2009 21:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 80,000 | $0.00 Strike: $19.28 | $0.00 |
DisclosureSEC source: 0001127602-09-025366 · form4.xml · derivative · entry 7 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2010-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2009 Filed Dec 16, 2009 21:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 80,000 | $32.37 | $2,589,840.00 |
DisclosureSEC source: 0001127602-09-025366 · form4.xml · nonDerivative · entry 2 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,179.3773 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $32.30 and $32.45 per share. Read SEC document |
| December 14, 2009 Filed Dec 16, 2009 21:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 80,000 | $19.28 | $1,542,504.00 |
DisclosureSEC source: 0001127602-09-025366 · form4.xml · nonDerivative · entry 1 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,179.3773 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2009 Filed Aug 19, 2009 20:08 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 251,520 | $0.00 Strike: $20.88 | $0.00 |
DisclosureSEC source: 0001127602-09-017670 · form4.xml · derivative · entry 7 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 251,520 shares Expires 2009-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Options becomes exercisable in three equal annual installments, commencing 9/1/2002. Read SEC document |
| August 17, 2009 Filed Aug 19, 2009 20:08 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 251,520 | $33.96 | $8,540,864.64 |
DisclosureSEC source: 0001127602-09-017670 · form4.xml · nonDerivative · entry 2 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,179.3773 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $33.89 and $34.38 per share. Read SEC document |
| August 17, 2009 Filed Aug 19, 2009 20:08 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 251,520 | $20.88 | $5,250,480.00 |
DisclosureSEC source: 0001127602-09-017670 · form4.xml · nonDerivative · entry 1 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 458,699.3773 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 192,709 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-09-008772 · form4.xml · derivative · entry 6 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,709 Underlying: Common Stock · 192,709 shares Expires 2016-04-01 F2 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 16,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-008772 · form4.xml · nonDerivative · entry 1 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,719 F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2012 and 50% on 04/01/2014. Read SEC document |
| February 18, 2009 Filed Feb 20, 2009 21:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 20,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-004385 · form4.xml · nonDerivative · entry 1 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,348.0129 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| April 01, 2008 Filed Apr 3, 2008 20:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 172,973 | $0.00 Strike: $41.17 | $0.00 |
DisclosureSEC source: 0000064803-08-000046 · doc.xml · derivative · entry 15 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,973 Underlying: Common Stock · 172,973 shares Expires 2015-04-01 F6 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/1/2009. Read SEC document |
| April 01, 2008 Filed Apr 3, 2008 20:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 12,145 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-08-000046 · doc.xml · nonDerivative · entry 2 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,704 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 04/01/2011 and 50% on 04/01/2013. Read SEC document |
| February 12, 2008 Filed Feb 14, 2008 21:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 14,494 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-08-000024 · doc.xml · nonDerivative · entry 3 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,648.9257 F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| June 11, 2007 Filed Jun 12, 2007 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 197,652 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0000064803-07-000116 · doc.xml · derivative · entry 16 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 197,652 shares Expires 2012-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 01/02/03. Read SEC document |
| June 11, 2007 Filed Jun 12, 2007 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 197,652 | $37.49 | $7,410,368.78 |
DisclosureSEC source: 0000064803-07-000116 · doc.xml · nonDerivative · entry 2 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,681 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| June 11, 2007 Filed Jun 12, 2007 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 197,652 | $14.96 | $2,957,368.05 |
DisclosureSEC source: 0000064803-07-000116 · doc.xml · nonDerivative · entry 1 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 136,089 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0000064803-07-000085 · doc.xml · derivative · entry 15 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,089 Underlying: Common Stock · 136,089 shares Expires 2014-04-02 F6 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/2/2008. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 13,174 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000085 · doc.xml · nonDerivative · entry 2 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,659 F2 · shares: Consist of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 100% on 12/20/2010. Read SEC document |
| April 02, 2007 Filed Apr 18, 2007 20:19 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 13,074 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000088 · doc.xml · nonDerivative · entry 2 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,559 F2 · shares: Consist of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 100% on 12/20/2010. Read SEC document |
| February 12, 2007 Filed Feb 20, 2007 18:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 9,436 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000031 · doc.xml · nonDerivative · entry 3 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,110 F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| April 03, 2006 Filed Apr 5, 2006 20:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 138,309 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001194405-06-000012 · doc.xml · derivative · entry 2 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,309 Underlying: Common Stock · 138,309 shares Expires 2013-04-03 F1 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/3/07 Read SEC document |
| April 03, 2006 Filed Apr 5, 2006 20:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 12,485 | $0.00 | $0.00 |
DisclosureSEC source: 0001194405-06-000012 · doc.xml · nonDerivative · entry 1 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,485 Read SEC document |
| February 16, 2006 Filed Feb 21, 2006 21:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 10,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001194405-06-000004 · doc.xml · nonDerivative · entry 2 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,674 F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receirpt of which the reporting person has elected to defer. Read SEC document |
| February 15, 2005 Filed Feb 17, 2005 21:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 6,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001194414-05-000001 · c0001194414d20050217f4f.xml · nonDerivative · entry 1 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,856 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| January 05, 2005 Filed Jan 7, 2005 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 50,000 | $0.00 Strike: $44.89 | $0.00 |
DisclosureSEC source: 0001194405-05-000004 · c0001194414d20050107f4f.xml · derivative · entry 2 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2012-01-05 F1 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 01/05/2006. Read SEC document |
| January 05, 2005 Filed Jan 7, 2005 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001194405-05-000004 · c0001194414d20050107f4f.xml · nonDerivative · entry 1 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,525 Read SEC document |
| September 08, 2004 Filed Sep 10, 2004 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock (PEP) | 6,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001194414-04-000001 · c0001194414d20040910f4f.xml · nonDerivative · entry 4 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| September 08, 2004 Filed Sep 10, 2004 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | OtherCommon Stock (PEP) | 15,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001194414-04-000001 · c0001194414d20040910f4f.xml · nonDerivative · entry 3 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,981 F1 · kind: Change in form of ownership (vesting of formerly restricted shares). Read SEC document |
| September 08, 2004 Filed Sep 10, 2004 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | OtherCommon Stock | 15,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001194414-04-000001 · c0001194414d20040910f4f.xml · nonDerivative · entry 1 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,989 F1 · kind: Change in form of ownership (vesting of formerly restricted shares). F2 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| February 16, 2004 Filed Feb 18, 2004 21:40 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 6,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001194413-04-000003 · c0001194414d20040218f4f.xml · nonDerivative · entry 5 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,331 Read SEC document |
| January 08, 2004 Filed Jan 12, 2004 20:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 50,000 | $0.00 Strike: $35.34 | $0.00 |
DisclosureSEC source: 0001194416-04-000002 · c0001194414d20040112f4f.xml · derivative · entry 4 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2011-01-08 F1 · derivative.exercise_date: Options become exercisable in three equal annual installments, commencing 01/08/2005. Read SEC document |
| January 08, 2004 Filed Jan 12, 2004 20:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001194416-04-000002 · c0001194414d20040112f4f.xml · nonDerivative · entry 1 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,344 Read SEC document |
| December 31, 2003 Filed Feb 10, 2004 16:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantPhantom Stock Credits · Derivative | 1,683 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001194405-04-000004 · c0001194414d20040210f5f.xml · derivative · entry 6 RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,683 Underlying: Common Stock · 1,683 shares Expires not disclosed F5 · derivative.exercise_price: Each share credit is equivalent to one share; 1-for-1 conversion. F6 · shares: Reflects 2001, 2002 and 2003 year end company match share credits of 846, 29 and 808, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. F6 · derivative.exercise_date: Reflects 2001, 2002 and 2003 year end company match share credits of 846, 29 and 808, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. F6 · derivative.expiration_date: Reflects 2001, 2002 and 2003 year end company match share credits of 846, 29 and 808, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.